Topic Paragraphs
FDA Accomplishments for the American People
FDA Seizes 7-OH Opioids to Protect American Consumers
The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.
Read MoreRecalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Dec 03
Fromm Family Foods Voluntarily Recalls Bonnihill BeefiBowls Food for Dogs Due to Potential Foreign Material Contamination
Animal & Veterinary, Food & Beverages
Nov 28
Mondelēz Global LLC Conducts Limited Voluntary Recall of 1 SKU of RITZ Peanut Butter Cracker Sandwiches in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama
Food & Beverages
Nov 26
Silvestri Sweets Issues Voluntary Allergy Alert on Undeclared Pecan and Wheat in Cookie Butter Holiday Bark and Pecan, Cranberry & Cinnamon Holiday Bark
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program
ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
Recently Published Guidances
Dec 03
QTc Information in Human Prescription Drug and Biological Product Labeling
Biologics, Drugs
Dec 03
eCopy Program for Medical Device Submissions
Biologics, Medical Devices
Dec 02
Monoclonal Antibodies: Streamlined Nonclinical Safety Studies
Drugs